glp-1 supply chain news The Ozempic Effect: How Drugs Are Transforming U.S. Food & Beverage and Pharma Logistics Disruptive Innovations Shaping the GLP-1
Description
The patients were grouped into patients with type 2 diabetes or overweight/obesity prescribed GLP-1 vs
New data is regularly published, finding new or magnified benefits of GLP-1s
Hum a song in your head
In the SURPASS-1 trial, TZP 10 mg resulted in a mean decrease in SBP of 5.2 mmHg, which is more significant than that with a placebo
doi: 10.1111/j.1365-2826.2012.02364.x
Given their ability to modulate reward pathways shared by both food and substance use (particularly the mesolimbic dopamine system), GLP-1RAs may offer a novel approach to reducing alcohol cravings and consumption
